Related Experiment Videos
Post-transplant nephrotic syndrome: A comprehensive clinicopathologic study.
Ulkem Yakupoglu1, Elzbieta Baranowska-Daca, Daniel Rosen
1Department of Pathology, Renal Section, Baylor College of Medicine, and The Methodist Hospital, The kidney Institute of Houston, Texas 77030, USA.
Kidney International
|May 20, 2004
Summary
Post-transplant nephrotic syndrome (NS) has distinct features and outcomes. Remission, especially with de novo glomerular disease, improves graft survival, unlike chronic allograft nephropathy.
Area of Science:
- Nephrology
- Transplantation Immunology
- Glomerular Diseases
Background:
- Post-transplant nephrotic syndrome (NS) lacks a clear definition.
- Understanding its characteristics is crucial for managing kidney transplant recipients.
Purpose of the Study:
- To define the clinicopathologic features of post-transplant nephrotic syndrome.
- To investigate factors influencing remission and graft survival.
Main Methods:
- Retrospective study of 74 renal transplant recipients with NS.
- Analysis of biopsy findings, treatment modalities, and clinical outcomes.
- Comparison of outcomes based on etiology of NS and remission status.
Main Results:
- Chronic allograft nephropathy (CAN) and de novo glomerular disease (GN) were common causes of NS.
- Remission rates varied by etiology, being lowest for CAN (9%) and highest for de novo GN (47%).
- NS remission was associated with better graft survival (88% vs. 18%), particularly in de novo GN.
Conclusions:
- Post-transplant NS exhibits unique features influencing prognosis.
- Early recognition and treatment, especially for de novo GN, may improve outcomes.
- Distinct pathogenetic mechanisms and therapeutic strategies are implied.